115 related articles for article (PubMed ID: 2853836)
1. Synthesis of 3H-Tyr-D-Ala-Gly-N(Me)Phe chloromethyl ketone--an opioid affinity label.
Varga E; Tóth G; Hepp J; Benyhe S; Simon J; Medzihradszky K; Borsodi A
Neuropeptides; 1988 Oct; 12(3):135-9. PubMed ID: 2853836
[TBL] [Abstract][Full Text] [Related]
2. Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone: a mu specific affinity label for the opioid receptor.
Benyhe S; Hepp J; Simon J; Borsodi A; Medzihradszky K; Wollemann M
Neuropeptides; 1987 Apr; 9(3):225-35. PubMed ID: 3037428
[TBL] [Abstract][Full Text] [Related]
3. Opioid receptor labeling with the chloromethyl ketone derivative of (3)H-Tyr-D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) I: Binding properties of 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl.
Oktem HA; Varga E; Hepp J; Medzihradzky K; Lajtha A; Borsodi A
Life Sci; 1991; 48(18):1757-62. PubMed ID: 1850494
[TBL] [Abstract][Full Text] [Related]
4. Opioid receptor labeling with the chloromethyl ketone derivative of [3H]Tyr-D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) II: Covalent labeling of mu opioid binding site by 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl ketone.
Oktem HA; Moitra J; Benyhe S; Toth G; Lajtha A; Borsodi A
Life Sci; 1991; 48(18):1763-8. PubMed ID: 1850495
[TBL] [Abstract][Full Text] [Related]
5. Identification of an opioid receptor subunit carrying the mu binding site.
Newman EL; Barnard EA
Biochemistry; 1984 Nov; 23(23):5385-9. PubMed ID: 6095896
[TBL] [Abstract][Full Text] [Related]
6. Irreversible labelling of rat brain opioid receptors by enkephalin chloromethyl ketones.
Benyhe S; Hepp J; Szucs M; Simon J; Borsodi A; Medzihradszky K; Wollemann M
Neuropeptides; 1986; 8(2):173-81. PubMed ID: 3020473
[TBL] [Abstract][Full Text] [Related]
7. Design of opioid peptides for a potential delta-receptor affinity label function: comparison with the mu-specific Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone.
Rónai AZ; Hepp J; Magyar A; Borsodi A; Medzihradszky K
Pharmacology; 1994 Aug; 49(2):121-31. PubMed ID: 7972321
[TBL] [Abstract][Full Text] [Related]
8. Affinity labelling of frog brain opioid receptors by dynorphin(1-10) chloromethyl ketone.
Benyhe S; Ketevan A; Simon J; Hepp J; Medzihradszky K; Borsodi A
Neuropeptides; 1997 Feb; 31(1):52-9. PubMed ID: 9574838
[TBL] [Abstract][Full Text] [Related]
9. Mu-receptor specificity of the opioid peptide irreversible reagent, [3H]DALECK.
Newman EL; Borsodi A; Toth G; Hepp F; Barnard EA
Neuropeptides; 1986; 8(4):305-15. PubMed ID: 3029618
[TBL] [Abstract][Full Text] [Related]
10. A potent peptide affinity reagent for the opiate receptor.
Venn RF; Barnard EA
J Biol Chem; 1981 Feb; 256(4):1529-32. PubMed ID: 6257675
[TBL] [Abstract][Full Text] [Related]
11. Covalent labeling of opioid receptors with 3H-D-Ala2-Leu5-enkephalin chloromethyl ketone. I. Binding characteristics in rat brain membranes.
Szücs M; Belcheva M; Simon J; Benyhe S; Tóth G; Hepp J; Wollemann M; Medzihradszky K
Life Sci; 1987 Jul; 41(2):177-84. PubMed ID: 3037220
[TBL] [Abstract][Full Text] [Related]
12. Covalent labeling of opioid receptors with 3H-D-Ala2-Leu5-enkephalin chloromethyl ketone. II. Binding characteristics in frog brain membranes.
Simon J; Szücs M; Benyhe S; Tóth G; Hepp J; Borsodi A; Wollemann M; Medzihradszky K
Life Sci; 1987 Jul; 41(2):185-92. PubMed ID: 3037221
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and binding characteristics of the highly delta-specific new tritiated opioid peptide, [3H]deltorphin II.
Búzás B; Tóth G; Cavagnero S; Hruby VJ; Borsodi A
Life Sci; 1992; 50(14):PL75-8. PubMed ID: 1313131
[TBL] [Abstract][Full Text] [Related]
14. Binding characteristics and analgesic activity of D-ALA2-Leu5-enkephalin chloromethyl ketone.
Szücs M; Benyhe S; Borsodi A; Wollemann M; Jancsó G; Szécsi J; Medzihradszky K
Life Sci; 1983 Jun; 32(24):2777-84. PubMed ID: 6304443
[TBL] [Abstract][Full Text] [Related]
15. Affinity labeling of the mu opioid receptor in bovine striatal membranes with [3H]-14 beta-(bromoacetamido)-7,8-dihydromorphine.
Bidlack JM; Kaplan RA; Subbramanian RA; Seyed-Mozaffari A; Archer S
Biochemistry; 1993 Jul; 32(26):6703-11. PubMed ID: 7687147
[TBL] [Abstract][Full Text] [Related]
16. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
17. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
18. Specificity of the opioid affinity reagent, DALECK, in a set of isolated tissue assay systems.
Peers E; Shaw JS; Rance MJ; Barnard EA
Neuropeptides; 1986; 8(4):317-25. PubMed ID: 3029619
[TBL] [Abstract][Full Text] [Related]
19. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
20. Amino acids and peptides. XXXVI. Synthesis of enkephalin chloromethyl ketone and evaluation of its inhibitory activity against endopeptidase 22.19.
Taguchi H; Nishiyama Y; Camargo AC; Okada Y
Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):2038-9. PubMed ID: 8293527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
